Page last updated: 2024-08-24

imiquimod and B-Cell Leukemia

imiquimod has been researched along with B-Cell Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Li, W; Yang, C; Yang, W	1

Other Studies

1 other study(ies) available for imiquimod and B-Cell Leukemia

Article	Year
Knockdown of Bcl-3 alleviates psoriasis and dyslipidemia comorbidity by regulating Akt pathway. Allergologia et immunopathologia, 2022, Volume: 50, Issue:6 Topics: Animals; Apolipoproteins E; Cholesterol; Comorbidity; Disease Models, Animal; Dyslipidemias; Glycogen Synthase Kinase 3 beta; Imiquimod; Leukemia, B-Cell; Mice; Mice, Inbred BALB C; NF-kappa B; Proto-Oncogene Proteins c-akt; Psoriasis; RNA, Small Interfering; Skin	2022

Article

Year

Knockdown of Bcl-3 alleviates psoriasis and dyslipidemia comorbidity by regulating Akt pathway.

Allergologia et immunopathologia, 2022, Volume: 50, Issue:6

Topics: Animals; Apolipoproteins E; Cholesterol; Comorbidity; Disease Models, Animal; Dyslipidemias; Glycogen Synthase Kinase 3 beta; Imiquimod; Leukemia, B-Cell; Mice; Mice, Inbred BALB C; NF-kappa B; Proto-Oncogene Proteins c-akt; Psoriasis; RNA, Small Interfering; Skin

2022